Nicole Hamblett
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Nicole Hamblett sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Nicole Hamblett: 8 sponsored US clinical trials, 1 recruiting.
Nicole Hamblett sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Cystic Fibrosis, with 3 trials.
Upper-quartile sponsor footprint
Nicole Hamblett sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
NCT06504589
The PROMISE Pediatric Study 6 to 11 Years Old
NCT04613128
CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes
NCT03350828
Rethinking Early Airway Clearence Therapies
NCT07696338
Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study
NCT06350461
Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy
NCT04378153
Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study
NCT06350474
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function
NCT04038047
Therapeutic Areas
What is open in the Nicole Hamblett pipeline
1 recruiting of 8 indexed (13% open); 4 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Cystic Fibrosis (3 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Nicole Hamblett: open-pipeline peers nationwide
Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Nicole Hamblett sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this Nicole Hamblett page
8 registered trials is a research-attention snapshot, not an endorsement of Nicole Hamblett or any single study.
- 1 of Nicole Hamblett's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cystic Fibrosis is the condition Nicole Hamblett studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cystic Fibrosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Nicole Hamblett pipeline card: 8 registered trials from official public datasets.Report a data error.